Unum Group (NYSE:UNM) Announces $0.46 Quarterly Dividend

Key Points

• Unum Group announced a quarterly dividend of $0.46 per share, with stockholders of record on October 24th set to receive payment on November 14th.
• The company's payout ratio stands at 17.1%, indicating its dividend is well covered by earnings, with expected earnings of $9.87 per share next year.
• After recent brokerage upgrades, the stock has an average rating of "Moderate Buy" and a consensus price target of $93.23.

Unum Group (NYSE:UNM - Get Free Report) announced a quarterly dividend on Thursday, October 9th. Stockholders of record on Friday, October 24th will be given a dividend of 0.46 per share by the financial services provider on Friday, November 14th. This represents a c) dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Friday, October 24th.

Unum Group has a payout ratio of 17.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect Unum Group to earn $9.87 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 17.0%.

Unum Group Price Performance

NYSE UNM opened at $76.68 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.31. Unum Group has a 12-month low of $61.28 and a 12-month high of $84.48. The company has a market capitalization of $13.06 billion, a PE ratio of 9.17, a price-to-earnings-growth ratio of 1.33 and a beta of 0.36. The firm's 50 day moving average is $73.14 and its 200-day moving average is $77.11.

Unum Group (NYSE:UNM - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The financial services provider reported $2.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.23 by ($0.16). Unum Group had a net margin of 11.77% and a return on equity of 13.44%. The business had revenue of $3.36 billion during the quarter, compared to analyst estimates of $3.35 billion. During the same quarter last year, the business earned $2.16 earnings per share. Unum Group's revenue for the quarter was up 4.0% on a year-over-year basis. Unum Group has set its FY 2025 guidance at 8.500-8.50 EPS. Equities research analysts anticipate that Unum Group will post 9.14 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on UNM. Wolfe Research upgraded shares of Unum Group to a "strong-buy" rating in a report on Tuesday, September 16th. Keefe, Bruyette & Woods reaffirmed an "outperform" rating and set a $95.00 price objective (down from $100.00) on shares of Unum Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. lifted their price objective on shares of Unum Group from $87.00 to $96.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 8th. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Unum Group in a research report on Wednesday. Finally, Evercore ISI reduced their price objective on shares of Unum Group from $100.00 to $96.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $93.23.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.